The importance of the methodology and sample matrix when interpreting chromogranin A results
Clin Chem Lab Med
.
2019 Oct 25;57(11):e291-e293.
doi: 10.1515/cclm-2019-0358.
Authors
Peter A Kavsak
1
2
3
,
John Beattie
3
,
Angela C Rutledge
4
Affiliations
1
Juravinski Hospital and Cancer Centre, 711 Concession Street, Hamilton, L8V 1C3 ON Canada.
2
McMaster University, Hamilton, ON, Canada.
3
Hamilton Health Sciences, Hamilton, ON, Canada.
4
London Health Sciences Centre and Western University, London, ON, Canada.
PMID:
31377733
DOI:
10.1515/cclm-2019-0358
No abstract available
Keywords:
Kryptor; chromogranin A; immunoassay; matrix.
Publication types
Letter
MeSH terms
Biomarkers, Tumor / metabolism*
Chromogranin A / metabolism*
Diagnostic Tests, Routine / methods*
Humans
Substances
Biomarkers, Tumor
Chromogranin A